基于影像组学特征在术前预测非小细胞肺癌患者肿瘤分化程度
回顾性纳入487例经病理确诊的非小细胞肺癌患者,从增强CT图像提取591个影像组学特征并构建由9个特征组成的影像组学标签;该标签在训练集区分低、高分化程度的AUC为0.763、敏感度0.750、特异度0.665、准确率0.687,在184例连续患者组成的独立验证集中AUC为0.782、敏感度0.608、特异度0.752、准确率0.712,结论认为该标签可能是区分低分化与高分化的有用影像生物标志物。
要点
- 基于增强CT的9个影像组学特征标签可在术前预测非小细胞肺癌的肿瘤分化程度。
- 验证集区分低分化与高分化程度的AUC为0.782,敏感度0.608、特异度0.752、准确率0.712。
- 训练集对应AUC为0.763、敏感度0.750、特异度0.665、准确率0.687。
核心结论
- 基于增强CT图像的影像组学标签可能是区分非小细胞肺癌低分化与高分化的有用影像生物标志物。
研究设计与样本
- 回顾性纳入487例经病理确诊的非小细胞肺癌患者,从每例肿瘤的增强CT图像提取591个影像组学特征。
- 采用最小冗余最大相关算法和逻辑回归模型进行降维、特征选择和影像组学标签构建。
- 使用受试者工作特征曲线分析评估标签性能,计算AUC、敏感度、特异度、准确率以量化标签与肿瘤分化程度的关联。
- 独立验证集包含184例连续的非小细胞肺癌患者。
诊断标准与关键数值
- 构建了基于9个影像组学特征的标签,用于区分低分化与高分化肿瘤分化程度。
- 训练集:AUC=0.763,敏感度=0.750,特异度=0.665,准确率=0.687。
- 验证集:AUC=0.782,敏感度=0.608,特异度=0.752,准确率=0.712。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Poorly differentiated non-small cell lung cancer (NSCLC) indicated a poor prognosis and well-differentiated NSCLC indicates a noninvasive nature and good prognosis. The purpose of this study was to build and validate a radiomics signature to predict the degree of tumor differentiation (DTD) for patients with NSCLC.
MATERIALS AND METHODS: A total of 487 patients with pathologically diagnosed NSCLC were retrospectively included in our study. Five hundred ninety-one radiomics features were extracted from each tumor from the contrast-enhanced computed tomography images. A minimum redundancy maximum relevance algorithm and a logistic regression model were used for dimension reduction, feature selection, and radiomics signature building. The performance of the radiomics signature was assessed using receiver operating characteristic analysis, and the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and accuracy were calculated to quantify the association between a signature and DTD. An independent validation set contained 184 consecutive patients with NSCLC.
RESULTS: A nine-radiomics-feature-based signature was built and it could differentiate low and high DTDs in the training set (AUC = 0.763, sensitivity = 0.750, specificity = 0.665, and accuracy = 0.687), and the radiomics signature had good discrimination performance in the validation set (AUC = 0.782, sensitivity = 0.608, specificity = 0.752, and accuracy = 0.712).
CONCLUSIONS: A radiomics signature based on contrast-enhanced computed tomography imaging is a potentially useful imaging biomarker for differentiating low from high DTD in patients with NSCLC.
引用
- Chen X, Fang M, Dong D, et al. A Radiomics Signature in Preoperative Predicting Degree of Tumor Differentiation in Patients with Non-small Cell Lung Cancer. Acad Radiol. 2018. PMID: 29572049. doi:10.1016/j.acra.2018.02.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。